Valuation: Olympus Corporation

Market Cap 1,856B 11.45B 10.01B 9.23B 8.49B 16.08B 1,101B 16.36B 110B 43.25B 538B 42.99B 42.05B P/E 2027 *
19.2x
P/E 2028 * 16x
Enterprise Value 1,925B 11.88B 10.39B 9.58B 8.81B 16.69B 1,143B 16.97B 114B 44.88B 559B 44.61B 43.63B EV / Sales 2027 *
1.81x
EV / Sales 2028 * 1.72x
Free-Float
94.53%
Yield 2027 *
1.76%
Yield 2028 * 1.85%
1 day-2.62%
1 week-2.40%
Current month+2.83%
1 month+2.58%
3 months+10.22%
6 months-17.30%
Current year-11.97%
1 week 1,729.5
Extreme 1729.5
1,817
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%-2.40%+4.30%-21.66% 11.77B
-0.21%+5.11%+28.28%+2.08% 198B
+2.99%-6.40%-24.15%+9.81% 134B
+0.19%+5.28%+4.14%-15.52% 141B
+1.13%-3.69%-58.30%-17.97% 63.36B
-0.32%-6.45%+14.05%-5.45% 51.87B
+1.34%+1.46%-24.75%-32.52% 43.77B
-2.25%+4.73%+19.69%+14.32% 38.18B
-1.76%+1.55%+29.11%+38.55% 36.96B
+2.68%-2.07%-14.85%-21.99% 28.05B
Average +0.25%-2.14%-2.25%-5.04% 74.77B
Weighted average by Cap. +0.68%-1.99%+0.49%-2.94%

Financials

2027 *2028 *
Net sales 1,065B 6.57B 5.75B 5.3B 4.87B 9.23B 632B 9.39B 63.27B 24.83B 309B 24.68B 24.14B 1,107B 6.83B 5.97B 5.51B 5.06B 9.59B 657B 9.75B 65.73B 25.79B 321B 25.63B 25.07B
Net income 98.47B 607M 531M 490M 450M 853M 58.45B 868M 5.85B 2.29B 28.57B 2.28B 2.23B 118B 725M 634M 585M 538M 1.02B 69.78B 1.04B 6.98B 2.74B 34.11B 2.72B 2.66B
Net Debt 69.9B 431M 377M 348M 320M 606M 41.49B 616M 4.15B 1.63B 20.28B 1.62B 1.58B 51.9B 320M 280M 258M 237M 450M 30.81B 457M 3.08B 1.21B 15.06B 1.2B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-15 ¥1,747.00 -2.62% 3,274,100
26-07-14 ¥1,794.00 +1.04% 3,904,800
26-07-13 ¥1,775.50 +1.25% 3,629,900
26-07-10 ¥1,753.50 +0.72% 3,945,500
26-07-09 ¥1,741.00 -1.64% 3,166,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,747.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+9.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock